Disease-Modifying Drugs for Multiple Sclerosis Must Be Globally Available According to Therapeutic Guidelines Suitable to Different Regions of the World

AuthID
P-002-4WW
1
Author(s)
Tipo de Documento
Editorial Material
Year published
2012
Publicado
in ARQUIVOS DE NEURO-PSIQUIATRIA, ISSN: 0004-282X
Volume: 70, Número: 10, Páginas: 761-762 (2)
Indexing
Publication Identifiers
Pubmed: 23060099
Wos: WOS:000309719600001
Source Identifiers
ISSN: 0004-282X
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.